Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics.
38438002
Alternative title(s) : (de) Nanoteilchen für immuntherapie (fr) Nanoparticules pour immunothérapie
TTO:6.0650
| Identifier | Country code | Kind code | Date issued |
CA2661700 | CA | C | 2020-07-07 |
ES2709391 | ES | T3 | 2019-04-16 |
EP1993511 | EP | B1 | 2018-10-31 |
EP1993511 | EP | A4 | 2014-11-05 |
JP5506196 | JP | B2 | 2014-05-28 |
AU2007217514 | AU | B2 | 2013-02-21 |
CN101437491 | CN | B | 2013-01-02 |
US8021689 | US | B2 | 2011-09-20 |
JP2009527566 | JP | A | 2009-07-30 |
CN101437491 | CN | A | 2009-05-20 |
EP1993511 | EP | A2 | 2008-11-26 |
WO2007098254 | WO | A3 | 2008-09-25 |
US2008031899 | US | A1 | 2008-02-07 |
AU2007217514 | AU | A1 | 2007-08-30 |
CA2661700 | CA | A1 | 2007-08-30 |
WO2007098254 | WO | A2 | 2007-08-30 |